Allakos, Inc. (NASDAQ: ALLK), a clinical-stage biopharmaceutical company developing therapeutic monoclonal antibodies for treatment of inflammatory, and proliferative diseases, faced a setback with disappointing results from a crucial phase 3 trial named Enigma 2 and phase 2/3 Kryptos trial. The studies were evaluating the Company’s...
Technology Industry has been focused on minimizing the impact of COVID-19 and marching ahead with its innovations and breakthroughs, be it critical components for semiconductors, cutting-edge data analytics or programmatic advertising. We take a look at some tech companies that are impervious to the scare and...
Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific knowledge and a zeal for innovation to the table. Our biotech picks that are making strides in fields such as Hepatitis B, rare...
Fennec Pharmaceuticals (NASDAQ: FENC), a specialty pharmaceutical company, received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for PEDMARK™ (sodium thiosulfate), which was being developed as an intravenous administration for the prevention of ototoxicity...
This week we bring to you four companies, namely Sunworks (NASDAQ: SUNW), Progenity Inc (NASDAQ: PROG), Upland Software Inc (NASDAQ: UPLD) and Purple Innovation Inc (NASDAQ: PRPL) that could turn out be to vulnerable investments, in view of the challenges being faced by these companies, such as...
ShotSpotter, Inc. (NASDAQ: SSTI) manufacturers ShotSpotter® Flex™, a gun detection location and forensic analyses system, which use acoustic sensors with audio triangulation capability, to pinpoint where shots are fired. The Company offers an end-to-end precision policing platform that enables law enforcement to pre-empt and provide...
“Realignment” of Management Team Rafael Holdings, Inc. (NYSE: RFL), announced the realignment of its management team, including the departure of the CEO Ameet Mallik, William Conkling, chief commercial and business officer and Ashok David Marin, chief legal officer among others. The responsibilities of the CEO will...
Technology Industry has been focused on minimizing the impact of COVID-19 and marching ahead with its innovations and breakthroughs, be it critical components for semiconductors, world-class data center solutions or cutting-edge data analytics and outsourcing facilities. We take a look at some tech companies that are...
Volta Inc. (NYSE: VLTA) entered into a business combination agreement with Tortoise Acquisition Corp II, a special purpose acquisition company and started trading on the NYSE on August 27,2021. The transaction brought in $400 million in gross proceeds, which will be utilised to accelerate Volta's...
Termination of Collaboration with Roche Atea Pharmaceuticals, Inc. (NASDAQ: AVIR), a clinical-stage biopharmaceutical company, announced the termination of its strategic collaboration with Roche (OTCQX: RHHBY), for the joint development of AT-527, intended for the treatment of COVID-19. The agreement will be terminated on February 10,2022 and...
